Evidence map›Paper›PMID 33815388›Full record

ArticleFrontiers in immunology2021

Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS or Anti-CD3 and Anti-CD28.

Nathan Lawlor, Djamel Nehar-Belaid, Jessica D S Grassmann, Marlon Stoeckius, Peter Smibert, Michael L Stitzel, Virginia Pascual, Jacques Banchereau, Adam Williams, Duygu Ucar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A systems pharmacology-basedFrontiers in veterinary science · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Nathan LawlorThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Djamel Nehar-BelaidThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Jessica D S GrassmannThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Marlon StoeckiusNew York Genome Center, New York, NY, United States.
Peter SmibertNew York Genome Center, New York, NY, United States.
Michael L StitzelThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Virginia PascualRonay Menschel Professor of Pediatrics, Drukier Institute, Weill Cornell Medicine, New York, NY, United States.
Jacques BanchereauThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Adam WilliamsThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Duygu UcarThe Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.
Jackson Laboratory · USNew York Genome Center · USCornell University · USUniversity of Connecticut · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Project 2: The Isoform repertoire and epigenome of Pediatric SLEP50AR070594 · NIAMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Maria Virginia Pascual · 2016 to 2026
$18.6M
NCI NIH HHS P30 CA034196NIAMS NIH HHS P50 AR070594
6 · The paper itself

Abstract

Immune cell activation assays have been widely used for immune monitoring and for understanding disease mechanisms. However, these assays are typically limited in scope. A holistic study of circulating immune cell responses to different activators is lacking. Here we developed a cost-effective high-throughput multiplexed single-cell RNA-seq combined with epitope tagging (CITE-seq) to determine how classic activators of T cells (anti-CD3 coupled with anti-CD28) or monocytes (LPS) alter the cell composition and transcriptional profiles of peripheral blood mononuclear cells (PBMCs) from healthy human donors. Anti-CD3/CD28 treatment activated all classes of lymphocytes either directly (T cells) or indirectly (B and NK cells) but reduced monocyte numbers. Activated T and NK cells expressed senescence and effector molecules, whereas activated B cells transcriptionally resembled autoimmune disease- or age-associated B cells (e.g., CD11c, T-bet). In contrast, LPS specifically targeted monocytes and induced two main states: early activation characterized by the expression of chemoattractants and a later pro-inflammatory state characterized by expression of effector molecules. These data provide a foundation for future immune activation studies with single cell technologies (https://czi-pbmc-cite-seq.jax.org/).

Indexed as

AdultAntibodies, MonoclonalCD28 AntigensCD3 ComplexCells, CulturedCellular SenescenceChemotaxisFemaleGene Expression ProfilingHigh-Throughput Screening AssaysHumansImmunizationLeukocytes, MononuclearLipopolysaccharidesLymphocyte ActivationMaleAntibodies, MonoclonalCD28 AntigensCD3 ComplexLipopolysaccharidesantiCD3/CD28CITE-seqimmune cell activationimmune responsesLPSperipheral blood mononuclear cellssingle cell profiling

Identifiers

PMID33815388
PMCPMC8010670
OpenAlexW3136036259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.